Rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK) targets glucocorticoid receptor signaling: a longitudinal cerebrospinal fluid proteome study
Authors
David Herzog,
Natarajan PerumalCaroline Manicam,
Giulia Treccani,
Jens Nadig,
Milena Rossmanith,
Jan Engelmann,
Tanja Jene,
Annika Hasch,
Michael Kooij,
Klaus Lieb,
Nils Gassen,
Franz Grus +11 authors
,
Marianne Müller Tip Tip